NCT05394818View on ClinicalTrials.gov

The Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 21, 2022

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Advanced Solid Tumor
Interventions
DRUG

SHR-A2009

The total dosage of SHR-A2009 was calculated according to the weight weighing results of the subjects before each administration, and was administered by intravenous drip.

Trial Locations (1)

100039

Chinese PLA General Hospital-Department of Medical Oncology, Beijing

All Listed Sponsors
lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY